Envestnet Asset Management »

Rigel Pharmaceuticals shares owned by Envestnet Asset Management

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Envestnet Asset Management from 13F filings

Historical chart of Envestnet Asset Management investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Envestnet Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $225k 5.3k 42.83

More positions owned by Envestnet Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr Core Univrsl Usd (IUSB)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Core Msci Emkt (IEMG)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Value Etf (VTV)
NVIDIA Corporation (NVDA)
Ishares Tr Eafe Value Etf (EFV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr S&p 100 Etf (OEF)
Ishares Tr Core Us Aggbd Et (AGG)

View all positions for Envestnet Asset Management

Top funds holding Rigel Pharmaceuticals

BlackRock
State Street Corporation
Vanguard Group
Armistice Capital
Goldman Sachs Group
Marshall Wace
Capitolis Liquid Global Markets
LSV Asset Management
Renaissance Technologies
Acadian Asset Management
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Jane Street
D. E. Shaw & Co
Soleus Capital Management

View all funds holding Rigel Pharmaceuticals